BACKGROUND: Implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000 (BCCPTA) allowed states to extend Medicaid to any woman aged <65 without insurance screened and found to need treatment either for breast or cervical cancer or for a precancerous cervical condition through the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) or in Georgia, other provider sites. METHODS: The authors used linked Georgia Comprehensive Cancer Registry (GCCR) and Medicaid data to test the: 1) likelihood of Medicaid enrollment in a given month and 2) time-to-enrollment (months) for those eventually enrolling. The authors used difference-in-differences analysis to estimate the effects of BCCPTA for breast or cervical cancer cases relative to a control group of women with other cancers. The authors controlled for sociodemographics, stage at diagnosis, year of diagnosis, and county level factors related to insurance levels in the area. RESULTS: Compared with the control cancer group, the hazard ratio of Medicaid enrollment for women with breast and cervical cancers increased post- vs pre-BCCPTA implementation. The estimated effect of this increase was that out of every 1000 women with breast cancer, BCCPTA led to 1.7 more (from 2.8 to 4.5 per month) enrolling in Medicaid. The results for women with local or later stages of cervical cancer indicated that of 1000 women with these cancers, the number enrolling in a given month increased by 3.4 due to BCCPTA. Results on time-to-enrollment indicated that the time between cancer diagnosis and enrollment was shortened by 7 to 8 months. CONCLUSIONS: The Georgia Medicaid program, in response to national legislation, increased the probability of women enrolling in Medicaid earlier and in turn, likely increased their cancer treatment options. Copyright (c) 2009 American Cancer Society.
BACKGROUND: Implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000 (BCCPTA) allowed states to extend Medicaid to any woman aged <65 without insurance screened and found to need treatment either for breast or cervical cancer or for a precancerous cervical condition through the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) or in Georgia, other provider sites. METHODS: The authors used linked Georgia Comprehensive Cancer Registry (GCCR) and Medicaid data to test the: 1) likelihood of Medicaid enrollment in a given month and 2) time-to-enrollment (months) for those eventually enrolling. The authors used difference-in-differences analysis to estimate the effects of BCCPTA for breast or cervical cancer cases relative to a control group of women with other cancers. The authors controlled for sociodemographics, stage at diagnosis, year of diagnosis, and county level factors related to insurance levels in the area. RESULTS: Compared with the control cancer group, the hazard ratio of Medicaid enrollment for women with breast and cervical cancers increased post- vs pre-BCCPTA implementation. The estimated effect of this increase was that out of every 1000 women with breast cancer, BCCPTA led to 1.7 more (from 2.8 to 4.5 per month) enrolling in Medicaid. The results for women with local or later stages of cervical cancer indicated that of 1000 women with these cancers, the number enrolling in a given month increased by 3.4 due to BCCPTA. Results on time-to-enrollment indicated that the time between cancer diagnosis and enrollment was shortened by 7 to 8 months. CONCLUSIONS: The Georgia Medicaid program, in response to national legislation, increased the probability of women enrolling in Medicaid earlier and in turn, likely increased their cancer treatment options. Copyright (c) 2009 American Cancer Society.
Authors: Joseph Lipscomb; Theresa W Gillespie; Michael Goodman; Lisa C Richardson; Lori A Pollack; A Blythe Ryerson; Kevin C Ward Journal: Breast Cancer Res Treat Date: 2012-01-26 Impact factor: 4.872
Authors: Sujha Subramanian; Florence K L Tangka; Donatus U Ekwueme; Justin Trogdon; Wesley Crouse; Janet Royalty Journal: Cancer Causes Control Date: 2015-04-04 Impact factor: 2.506
Authors: E Kathleen Adams; A Rana Bayakly; Alissa K Berzen; Sarah Blake; Peter Joski; Chunyu Li; Ingrid J Hall; Susan A Sabatino Journal: Cancer Causes Control Date: 2015-03-27 Impact factor: 2.506
Authors: Sarah M Lyon; Nicole M Benson; Colin R Cooke; Theodore J Iwashyna; Sarah J Ratcliffe; Jeremy M Kahn Journal: Am J Respir Crit Care Med Date: 2011-10-01 Impact factor: 21.405
Authors: Arash O Naghavi; Michelle I Echevarria; G Daniel Grass; Tobin J Strom; Yazan A Abuodeh; Kamran A Ahmed; Youngchul Kim; Andy M Trotti; Louis B Harrison; Kosj Yamoah; Jimmy J Caudell Journal: Cancer Date: 2016-08-01 Impact factor: 6.860
Authors: Siran M Koroukian; Paul M Bakaki; Mark Schluchter; Cynthia Owusu; Gregory S Cooper; Susan A Flocke Journal: J Oncol Pract Date: 2015-09-15 Impact factor: 3.840
Authors: Gery P Guy; Joseph Lipscomb; Theresa W Gillespie; Michael Goodman; Lisa C Richardson; Kevin C Ward Journal: Health Serv Res Date: 2014-12-10 Impact factor: 3.402